Diabetes Mellitus and Pneumococcal Pneumonia

Catia Cilloniz,Antoni Torres

DOI: https://doi.org/10.3390/diagnostics14080859

IF: 3.6

2024-04-23

Diagnostics

Abstract:Currently, there are more than 500 million people suffering from diabetes around the world. People aged 65 years or older are the most affected by this disease, and it is estimated that approximately 96% of diabetes cases worldwide are type 2 diabetes. People with diabetes mellitus are at an increased risk of infections such as pneumonia, due to a series of factors that may contribute to immune dysfunction, including hyperglycemia, inhibition of neutrophil chemotaxis, impaired cytokine production, phagocytic cell dysfunction, altered T cell-mediated immune responses and the co-existence of chronic comorbidities. Rates of infection, hospitalization and mortality in diabetic patients are reported to be higher than in the general population. Research into the risk of infectious diseases such as pneumonia in these patients is very important because it will help improve their management and treatment.

medicine, general & internal

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the risk of pneumonia in diabetic patients and its severity. Specifically, the paper focuses on the following aspects:

1. **The relationship between diabetes and pneumonia**: The paper discusses in detail that diabetic patients are more likely to be infected with pneumonia than the general population due to immune dysfunction and other reasons. In particular, high blood - glucose levels can affect the chemotaxis of neutrophils, the production of cytokines, the function of phagocytes, and T - cell - mediated immune responses. These factors together lead to an increased risk of pneumonia in diabetic patients.

2. **Clinical manifestations and management of pneumonia in diabetic patients**: The paper reviews the epidemiological characteristics, clinical manifestations, microbial causes, and management strategies of community - acquired pneumonia (CAP) in diabetic patients. It emphasizes the importance of understanding this information for improving the management and treatment of diabetic patients.

3. **Risk factor analysis**: The paper also analyzes the risk factors for pneumonia in diabetic patients, including long - term poor blood - glucose control, a long duration of diabetes, etc., and points out how these factors affect the incidence and severity of pneumonia.

4. **Preventive measures**: Finally, the paper proposes strategies to prevent pneumonia in diabetic patients, including lifestyle interventions, drug treatment to control blood - glucose levels, and raising public awareness of diabetes management.

Through these studies, the paper aims to provide clinicians with a more comprehensive understanding in order to better manage and prevent pneumonia in diabetic patients, thereby reducing its morbidity and mortality.